ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Unicredit Bank AG

Unicredit Bank AG (UC4KT1)

0.477
0.00
(0.00%)
Closed April 24 11:30AM

Professional-Grade Tools, for Individual Investors.

Premium

UC4KT1 News

Official News Only
0 articles were found
Rendering Error

UC4KT1 Financials

Financials
Error: 507

Discussion

View Full Feed
CatfishHunter CatfishHunter 5 minutes ago
You can't get to market approval on one clinical patient who looks like probably died a couple years ago. That's why it's BetaScam They're just milking investors for money.
RDGL
KRISGO KRISGO 6 minutes ago
Sometimes, unfortunate things happen when the timing just isn’t in our favor. All we can do now is stay hopeful.

NWBO was so stupid, reckless, and short-sighted that they submitted the new PIP trial design to the MHRA before the decision on the MAA was finalized.
That would alm
NWBO
pumper_stumper pumper_stumper 6 minutes ago
How did I guess? You mean, you don't want $10k just for showing that you had gains? Hmmm. How did I know that? lol
CBDW
tm3141 tm3141 6 minutes ago
what does that implicate?
FNMA
StockItOut StockItOut 7 minutes ago
Nils gave up on the bulls. Supposed production numbers released yet nary mention of or actual audit to substantiate his and Brookmount's assertions. And Brookmount is within its next fiscal year too.
BMXI
BIOCHEMUP BIOCHEMUP 7 minutes ago
Nice drop. 
TMC
Stock_Barber Stock_Barber 7 minutes ago
So are you going to apologize to everyone here when proven wrong?

Or will you and the other liars turn tale and hide?

100:1 it is the latter...


https://i.gifer.com/6eFV.gif
DBMM
Matteo2017 Matteo2017 7 minutes ago
Another post from KYNC on the discord siteWe are implementing different rewards for discord members. Soon to be announced. We have a great platform with Koinfold and growth is here. Super excited to have members here in Discord to give input to the app. you have great input and
KYNC
$7.00 or Nothing $7.00 or Nothing 8 minutes ago
Fed up of you calling people names

You phucking moron!!!
ELTP
swamp boy swamp boy 8 minutes ago
Doc please check and see if swamp boy signed up .Thanks ps called SEC yesterday will post anything they say, last time no info that was not public .They do have some new court info on the pay for web sites.
ENZC
JusDePomme JusDePomme 9 minutes ago
Goodness u need go back school man! Read it again before posted! Clearly stated there old finding
PSWW
SSKILLZ1 SSKILLZ1 9 minutes ago
VMIR (As Of 4/24/25)

Daily Performance
Value Microcap Index:+1.80%
Value Microcap Index Rebalanced:+1.98%

Overall Performance
Value Microcap Index: -15.50%
Value Microcap Index Rebalanced:-15.47%
mrmainstreet mrmainstreet 9 minutes ago
19 more days like this and I'm back to breakeven. Long way to go.
AMRN
SSKILLZ1 SSKILLZ1 9 minutes ago
VMIR (As Of 4/24/25)

Daily Performance
Value Microcap Index:+1.80%
Value Microcap Index Rebalanced:+1.98%

Overall Performance
Value Microcap Index: -15.50%
Value Microcap Index Rebalanced:-15.47%
ron_66271 ron_66271 10 minutes ago
New Filings on LIBOR Docket.

FNMA and FMCC are listed.

Yes, the Derivative Writers own FNMA and FMCC Money.

https://www.docketbird.com/court-cases/In-re-Libor-Based-Financial-Instruments-Antitrust-Litigation/nysd-1:2011-md-02262


FMCC
dia76ca dia76ca 10 minutes ago
Now that Dr. Gabelle is on board is a good time to review what she said in her Dec.12, 2024 presentation. She said that the Anavex drugs autophagy target extends to ALL neurodegenerative diseases (slide 14) ! WOW !
https://drive.google.com/file/d/1rB6b45TvqhP63RUYMSTA-oMKRnuumCzA/view
AVXL
ron_66271 ron_66271 11 minutes ago
New Filings on LIBOR Docket.

FNMA and FMCC are listed.

Yes, the Derivative Writers own FNMA and FMCC Money.

https://www.docketbird.com/court-cases/In-re-Libor-Based-Financial-Instruments-Antitrust-Litigation/nysd-1:2011-md-02262


FMCC
bigstocksnbonds bigstocksnbonds 11 minutes ago
Yes fun!!!!
blackhawks blackhawks 11 minutes ago
New American Apple iPhone assembly line. Here's your screwdriver, influence those tiny screws.
cashclan cashclan 11 minutes ago
That is a little



Over the top ...destroyed ? Ha!

I know $17 to $10 is the real RANT but with the Chinese market collapsing and this was before Trump you might see $6..as they would rather have them eating tree bark than feed their 1.4 billion.
janice shell janice shell 11 minutes ago
Can you explain how it is that in the past couple of years, "common sense" has come to mean the opposite of what it meant for the past few centuries?
CommodityCoverage CommodityCoverage 11 minutes ago
Doubling down on its vision to become a leading gold-copper-silver explorer in Mexico, Defiance Silver (DEF.v DNCVF) is advancing two flagship projects while expanding into one of North America’s hottest copper belts in acquiring Green Earth Metals

With resource updates underway at Za
DEF
europa7 europa7 12 minutes ago
Healthcare use cases...Hedera...

Healthcare Organizations Must Secure Identities as Social Engineering Attacks Increase
"...CrowdStrike’s new Global Threat Report finds voice phishing is up, China and North Korea are finding their way into the cloud, and more..."
Apr 10
HBARUSD
BOREALIS BOREALIS 12 minutes ago
Trump’s Job Rating Drops, Key Policies Draw Majority Disapproval as He Nears 100 Days

https://www.pewresearch.org/wp-content/uploads/sites/20/2025/04/pp_2025-4-23_trump-100-days_00-03.png

https://www.pewresearch.org/politics/2025/04/23/trumps-job-rating-drops-key-polici
Truthsocial Truthsocial 12 minutes ago
That's why you are here right...
And also I've seen tickers go from where RDGL is currently to dollars within 24 hrs and never look back at the skater behind...

Let's go RDGL
RDGL

Your Recent History

Delayed Upgrade Clock
Play Episode
8min
Proactive - Interviews for investors
Scancell fast-tracks melanoma study with NHS
Scancell Holdings PLC CEO Phillip L’Huillier joined Proactive's Stephen Gunnion with details of the company’s partnership with the NHS Cancer Vaccine Launchpad to accelerate patient recruitment for its SCOPE study evaluating the iSCIB1+ DNA cancer vaccine. L’Huillier described the deal as “a very positive endorsement for Scancell and for the medicines that we are developing,” noting that the therapy is showing promise in delivering long-term immune control in advanced melanoma patients. The NHS collaboration enables hospitals to more quickly access and offer the iSCIB1+ therapy as part of the trial, making Scancell the first UK company to partner with the platform and the first to offer a DNA cancer vaccine through it. He explained that the vaccine is given alongside checkpoint inhibitors, currently standard care, to boost response rates and prolong efficacy, especially where standard therapy alone sees limited, short-lived results. L’Huillier confirmed multiple SCOPE study data readouts are expected in 2025, with a larger development phase targeted for 2026. The company is also progressing its Modi-1 peptide vaccine and aims to further develop its GlyMab antibody platform, including the SC134 programme for small cell lung cancer. L’Huillier said his CEO priorities include sticking to development timelines, building strategic partnerships, and preparing the organisation for future phases. For more exclusive biotech interviews, visit Proactive's YouTube channel. Don't forget to like the video, subscribe to the channel, and enable notifications for future updates. #Scancell #CancerVaccine #BiotechNews #iSCIB1 #MelanomaResearch #NHSPartnership #DNAImmunotherapy #Modi1 #ClinicalTrials #OncologyInnovation #InvestorUpdate #ProactiveInvestors
Proactive - Interviews for investors
Tariffs, steel & strategy: Diales CEO Mark Wheeler speaks
Diales Group PLC (LON:DIAL) CEO Mark Wheeler talked with Proactive's Stephen Gunnion about the company’s global operations and how it supports clients across the engineering and construction sectors—particularly with dispute resolution, cost escalation claims, and complex project planning. Wheeler explained that Diales works with major contractors, joint ventures, government bodies, and clients across infrastructure, energy, and offshore projects. He said, “We support them with their contracts, planning, programming and claims and dispute resolution,” highlighting the company's niche expertise in large-scale, often novel engineering environments. In light of new US tariffs on steel and aluminum, Wheeler said Diales is seeing increased client inquiries and is well-positioned to provide strategic guidance. He noted the company’s experience with “cost escalation claims” and emphasised the value of early contractual advice to manage such risks. He also discussed supply chain challenges, especially where key components are manufactured globally. “One or two small components can really delay the delivery and completion of the construction of some quite significant pieces of equipment,” Wheeler noted. Finally, Wheeler addressed the ongoing share buyback program, which he described as popular with shareholders. He reiterated the company's belief that it is currently “the best value stock to be buying,” particularly given AIM market illiquidity. For more interviews like this one, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe to our channel, and turn on notifications to stay updated on future content. #DialesGroup #EngineeringDisputes #ConstructionSector #GlobalInfrastructure #ShareBuyback #AIMMarket #CostEscalation #SupplyChainIssues #SteelTariffs #MarkWheeler #ConstructionLaw #EnergyProjects #ProactiveInvestors
Proactive - Interviews for investors
European Green Transition co-founder Cathal Friel outlines growth strategy as he takes chair
European Green Transition PLC (AIM:EGT) founder and non-executive chairman Cathal Friel talked with Proactive's Stephen Gunnion about his formal move into the non-executive chairman role and the company’s strategy going forward. Friel shared how European Green Transition (EGT) aims to build value by acquiring distressed yet revenue-generating assets, a model he has successfully applied with previous companies such as Amryt Pharma and hVIVO. “Our model going forward is to acquire low-priced, distressed, good value assets, bolt them together,” he said, emphasising the need for revenue-generating components or the capacity to make acquisitions profitable from day one. He reflected on EGT’s IPO in April 2024 and his transition from other responsibilities, including his long tenure with hVIVO. With that chapter closed, he now brings more focus to EGT’s growth. Friel confirmed that the company still holds the majority of the £6.5 million raised, having only used a small portion on its rare earth asset in Sweden. Monetising that asset remains a priority. EGT's strategy continues to centre on small teams, tight cost control, and targeting multi-fold returns over a 24-month horizon. “I’ll be very careful of [the shareholders’] cash. It’s like mine,” Friel added. Visit Proactive’s YouTube channel for more interviews. Don’t forget to like this video, subscribe, and turn on notifications so you never miss an update. #CathalFriel #EuropeanGreenTransition #EGT #RareEarths #MergersAndAcquisitions #SmallCapInvesting #GreenEconomy #MiningInvestment #ShareholderValue #hVIVO #AmrytPharma #IPO
Proactive - Interviews for investors
Mosman Oil and Gas CEO on Vecta Project; drilling set to start in May
Mosman Oil and Gas Ltd (AIM:MSMN) CEO Andy Carroll talked with Proactive's Stephen Gunnion about the latest developments at the Vecta Helium Project in Colorado. Carroll confirmed that drilling is scheduled to begin by mid-May, with rig mobilisation underway and each of the five wells expected to take just two days to drill. Testing will follow before the rig moves to the next location, and a series of drilling updates will begin in approximately four weeks. “It’s the first time we’ve had a specific schedule with Vecta,” Carroll noted, emphasising the significance of this milestone for the company. He said each prospect within the five-well program has its own exploration risk profile, but collectively, the program boosts overall success probability. Carroll also discussed encouraging signs from nearby operations, such as the Blue Star and Helium One joint venture, though highlighted variability in helium concentrations across different wells. Mosman is also progressing other projects, including seismic activity at Coyote Wash and Sagebrush. Carroll said early results are promising, and meetings are ongoing with technical consultants and local stakeholders, including the Ute Mountain Ute Tribe. For more updates from Mosman Oil and Gas Ltd and other interviews, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to the channel, and enable notifications so you never miss a future update. #MosmanOilAndGas #HeliumExploration #VectaProject #ColoradoDrilling #OilAndGasUpdates #EnergySector #HeliumInvestment #SeismicExploration #CoyoteWash #SagebrushProject #ProactiveInvestors #EnergyNews #ResourceSector